期刊文献+

联合化疗与分段加速超分割放疗治疗晚期非小细胞肺癌 被引量:5

COMBINATION OF GP REGIMEN AND SPLIT-COURSE HYPERFRACTIONATED ACCELERATED IRRADIATION IN ADVANCED NON-SMALL CELL LUNG CANCER
下载PDF
导出
摘要 目的观察GP联合化疗与分段加速超分割放疗治疗局部晚期非小细胞肺癌的疗效。方法所选病人进行3个周期共12周的GP联合化疗和分段加速超分割放疗。联合化疗方案为在1~3天进行顺铂静脉滴注,第1、8天进行吉西他滨静脉滴注,二者浓度分别为30mg/m2和1000mg/m2,在4~8天进行分段加速超分割放疗,1.5Gy/次,2次/天,两次间隔最好6小时以上,共15Gy/周期,治疗达第3周期后,在第11~15天加常规放疗,2Gy/次,1次/天,使放疗的总剂量达到55Gy。3周期治疗后,再应用MVP方案化疗2个周期,4周为1个周期。结果 60例患者中,19例达CR,28例PR,有效率为81.6%。1年生存率为67.6%,2年生存率为59.1%。结论 GP化疗方案与分段加速超分割放疗联合治疗局部晚期非小细胞肺癌的疗效显著,生存期较长,毒副作用相对较小。 Objective To investigate the efficacy of GP regimen combined with split -course hyperfraetionated accelerated irradiation for advanced non - small cell lung cancer. Methods The treatment to patients was composed of 3 cycles of combined chemoradiotherapy at 4 -week intervals. Chemotherapy with cisplatin (30 mg/m^2) was administrated intravenously on days 1 - 3, and gemcitabine (1 000 mg/m^2 ) was on the first and eighth day, followed by radiotherapy on days 4 -8. A coarse of radiotherapy consisted of 1.5 Gy per fraction, twice a day (3 Gy per day) with a interval more than 6 h, for a total dose of 15 Gy. After the third cycle, additional irradiotherapy consisted of 2 Gy once a day was performed on days 11 - 15, for a total dose up to 55 Gy during 10 weeks. After three cycles, patients were given 2 additional cycles of chemotherapy with MVP regimen. Results Of the 60 patients, 19 had a complete remission and 28 a partial response, resulting in an overall response rate of 81.6%. The 1 - and 2 - year survival rates were 67.6% and 59.1%, respectively. Conclusion GP regimen combined with split - course hyperfractionated accelerated irradiation is effective and well tolerated for advanced non - small ceil lung cancer.
作者 汤新跃
出处 《现代医院》 2010年第8期52-54,共3页 Modern Hospitals
关键词 顺铂 吉西他滨 非小细胞肺癌 Cisplatin, Gemcitabine, Non -small cell lung cancer
  • 相关文献

参考文献12

  • 1CAFFO O.Radiosensitization with chemotherapeutic agents[J].Lung Cancer,2001,34(Suppl 4):S81-S90.
  • 2SHIGEMATSU N,KAWATA T,IHARA N,et al.Effect of combined treatment with radiation and low dose etoposide of cell survival[J].Anticancer Res,2001,21(1A):325-328.
  • 3TAKADA M,TUKUOKA M,KAWAHRA M,et al.Phase Ⅲ study of comcurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer:results of the Japan Clinical Oncology Group Study 9104[J].J Clin Oncol,2002,20(14):3054-3060.
  • 4湛永滋,黄昌杰,黄剑峰.同步放化疗治疗局部晚期非小细胞肺癌[J].中国临床医学,2009,16(6):841-843. 被引量:8
  • 5PINGON T,RUGGIERI S,BBUTIN C,et al.Alternating chemotherapy and accelerated split-course irradiation in locally advanced non-small cell lung carcinoma[J].Cancer,1999,85(10):2144-2150.
  • 6魏玲,李苏宜.铂类药物治疗食管癌的临床研究进展[J].中国肿瘤临床,2010,37(4):238-240. 被引量:14
  • 7林成辉,王云,香瑞珍.力尔凡联合长春瑞滨、卡铂治疗晚期非小细胞肺癌临床分析[J].国际医药卫生导报,2009,15(20):58-60. 被引量:5
  • 8SCHILLER J H,HARRINGTON D,BELANI C P,et al.Eastern Cooperative Oncology Group.Comparison of four chemotherapy regimens for advanced non small cell lung cancer[J].N Engl J Med,2002,346(2):92-98.
  • 9ALBEROLA V,CAMPS C,PROVENCIO M,et al.Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer:a Spanish Lung Cancer Group phase Ⅲ randomized trial[J].J Clin Oncol,2003,21(17):3207-3213.
  • 10SMIT E F,VAN MEERBEECK J P,LIANES P,et al.Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer:a phase Ⅲ trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group EORTC 08975[J].J Clin Oncol,2003,21(21):3909-3917.

二级参考文献41

共引文献35

同被引文献38

  • 1胡兵,沈克平.黄芪抗肿瘤作用及机制研究[J].中药材,2008,31(3):461-465. 被引量:60
  • 2金荣生.两种方法治疗胃肠肿瘤化疗所致呕吐的成本效果分析[J].中外医疗,2007,26(23):8-8. 被引量:3
  • 3葛红,蒋月,单娟.化疗加超分割放射治疗Ⅲ期非小细胞肺癌[J].临床肿瘤学杂志,2006,11(3):185-187. 被引量:2
  • 4于晓旻.放化疗与热化疗治疗Ⅲ期非小细胞肺癌临床分析[J].现代医院,2007,7(6):73-74. 被引量:2
  • 5S$chipper g,Loof A,de Groot J,et aI.SELDI TOF-MS of saliva: methodology and pre-treaament effecas[J].J Chromatogr B Analya Technol Biomed Life Sci,2007,15(1):45-53.
  • 6NCCN中国版专家组.NCCN非小细胞肺癌临床实践指南(中国版)[S]2011:22-23.
  • 7Kobayashi H, Uno T, Isobe K, et al. Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer [J]. Jpn J Clin Oncol,2010,d0(5):464-469.
  • 8Barriger R B, Forquer J A, Brabham J G, et al. A dose- volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy [ J ]. Int J Radiationoncol, Biology, Physics, 2012,82 ( 1 ) : 457- 462.
  • 9Kim T H, Cho K H, Pyo H R, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer [ J ]. Radiology, 2005,235 ( 1 ) : 208-215.
  • 10Rodrigues G, Lock M, D'Souza D, et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer--a systematic review [J]. Radiother Oncol, 2004, 71(2) : 127-38.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部